Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!

In Vivo Pharmacodynamic Evaluation of Pristane Induced Systemic Lupus Erythematosus (SLE) Mouse Model (CAT#: STEM-AE-0687-LGZ)

Introduction

Systemic lupus erythematosus (SLE) is a severe autoimmune disease characterized by dysfunction of immune regulation, overproduction of inflammatory cytokines and attack on normal tissues (heart, joints, skin, lungs, blood vessels, liver, kidneys, and the nervous system) by self-reactive cells and antibodies.<br />Pristane, also known as hydrocarbon oil (2,6,10,14- tetramethylpentadecane, TMPD), is capable of triggering a wide range of autoantibodies. Mice receive priatane develop an ascitic fluid enriched with monoclonal antibodies, local chronic inflammation (lipogranulomas), and a rheumatoid-like erosive arthritis. These clinical manifestations resemble SLE.




Principle

Experimental Animals: Balb/c, 6-8 weeks old, female
Modeling Reagent: Pristane
Modeling Method: Intraperitoneal injection of pristane on day 0

Applications

Autoimmune Disease

Procedure

1. Disease model construction.
2. Mice dosing.
3. Efficacy monitoring.
4. Biochemical detection of tissue samples.

Materials

• Sample Type: liquid or powder
Advertisement